Pregled bibliografske jedinice broj: 951961
GLASSY CELL CARCINOMA OF THE ENDOMETRIUM: A CASE REPORT
GLASSY CELL CARCINOMA OF THE ENDOMETRIUM: A CASE REPORT // 20th International Meeting of the European Society of Gynaecological Oncology
Beč, Austrija, 2017. str. 1233-1233 doi:10.1097/01.IGC.0000527296.86225.87 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 951961 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
GLASSY CELL CARCINOMA OF THE ENDOMETRIUM: A CASE REPORT
Autori
Mamić, Ivica ; Alvir, Ilija ; Šušnjar, Lucija ; Danolić, Damir ; Perić Balja, Melita ; Tomica, Darko ; Puljiz, Mario
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
20th International Meeting of the European Society of Gynaecological Oncology
/ - , 2017, 1233-1233
Skup
20th International Meeting of the European Society of Gynaecological Oncology
Mjesto i datum
Beč, Austrija, 04.11.2017. - 07.11.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
glass-cell carcinoma, endometrium
Sažetak
Aims: We present a case of 65-year old patient with glassy cell carcinoma of the endometrium, which is a rare neoplasm. To our knowledge, there are 14 previously cases reported in the literature. Microscopically, it is composed of malignant cells showing a "ground glass" cytoplasm, large nuclei with prominent nucleoli and distinct cell membranes. Nature of glassy cell carcinoma is still debatable, for now it is considered to be a poorly differentiated variant of adenosquamous carcinoma Method: A 65-year-old patient with ultrasonically found thickened endometrium underwent hysteroscopy. Histologically the tumor showed polypoid solid mass of epithelilal cells with ground glass cytoplasm and large nuclei with prominent nucleoli. Immunohistochemical analysis confirmed diagnosis of glassy cell carcinoma of the endometrium. The patient underwent bilateral salpingo-oophorectomy, total abdominal hysterectomy and radiation therapy. Results: She is alive, with no evidence of disease for 14 months after diagnosis. Conclusion: There are no specific recommendations about treatment of this rare disease. Detailed analysis of more cases is required to evaluate the nature of glassy cell carcinoma and to determine accurate prognosis for this infrequent entity.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore,
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE